YC W24 · Active

Eris Biotech

Our drugs engage the immune system to fight tumors

Class: Winter 2024
Status: Active
Industry: Healthcare
Location: Salt Lake City, UT, USA
Team size: 2

Website

http://www.erisbio.com

About

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.